Table 3 Prognostic factors affecting survival on univariate analysis
Factor | 1-yr. survival rate (%) | Hazard ratio (95% confidence interval) | p |
|---|---|---|---|
Age | |||
 ≧60 y.o. | 41.2 | 1.293(0.343-4.882) | 0.7 |
 < 60 y.o. | 60 | ||
Gender | |||
 Male | 44.4 | 0.427(0.054-3.344) | 0.42 |
 Female | 55.6 | ||
ECOG | |||
 0 | 66.7 | ||
 1 | 47.1 | 1.656(0.209-13.085) | 0.63 |
 2 | 50 | 2.155(0.134-34.555) | 0.59 |
BCLC | |||
 B | 50 | ||
 C | 50 | 0.915(0.117-7.176) | 0.93 |
Vascular extension (PVTT & IVCTT) | |||
 Yes | 37.5 | 4.920(0.628-38.559) | 0.13 |
 No | 83.3 | ||
Child-Pugh score | |||
 A | 55 | ||
 B | 0 | 17.303(2.301-130.129) | 0.01 |
Hepatitis virus | |||
 B | 50 | ||
 C | 25 | 1.938(0.483-7.774) | 0.35 |
Non B non C | 66.67 | 0.517(0.104-2.569) | 0.42 |
AFP (IU/mL) | |||
 <1500 | 60 | ||
 ≧1500 | 28.6 | 2.920(0.869-9.809) | 0.08 |
Tumor location | |||
 Right | 52.38 | ||
 Left | 0 | 7.629(0.783-74.297) | 0.08 |
Tumor type | |||
 Solitary | 54.6 | ||
 Multiple | 50 | 1.447(0.387-5.410) | 0.58 |
 Diffuse | 33.3 | 2.895(0.554-15.129) | 0.21 |
Tumor size | |||
 10 cm | 57.4 | ||
 >10 cm | 46.67 | 1.252(0.331-4.729) | 0.74 |
Radiation dose | |||
 40 Gy | 68.75 | ||
 < 40 Gy | 0 | 7.922(2.180-28.780) | 0.01 |
Pre-SBRT treatment | |||
 Yes | 66.7 | ||
 No | 38.5 | 2.576(0.679-9.777) | 0.16 |
Post-SBRT treatment | |||
 Yes | 66.7 | ||
 N0 | 43.8 | 2.056(0.443-9.542) | 0.36 |